FDA Adverse Event Injury Summary report: N

FINELINE II

MDR report key: 3213007 · Received July 9, 2013

Report

Report Number
2124215-2013-09958
Event Type
Injury
Date Received
July 9, 2013
Date of Event
June 18, 2013
Report Date
June 21, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS \REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT APPROXIMATELY FOUR DAYS POST-IMPLANT, THIS LEAD WAS CONFIRMED DISLODGED. IT WAS SUSPECTED THAT THE PRODUCT HAD RELOCATED DUE TO MULTIPLE CHEST DRAINAGE PROCEDURES, ON ACCOUNT OF A POST-PROCEDURE PNEUMOTHORAX. DURING THE REPOSITIONING ATTEMPTS, THE PHYSICIAN WAS NOT AWARE OF THE LEADS' ELECTRODE FIXATION MECHANISM AND THUS DISSATISFIED WITH THE LEADS INABILITY TO BE SUCCESSFULLY REPOSITIONED. A STABLE POSITION WAS UNATTAINABLE; NON-CAPTURE CONFIRMED AT 5V AT 0.5MS. THE LEAD WAS ULTIMATELY CUT, EXPLANTED AND DISCARDED. ANOTHER LEAD WAS SUCCESSFULLY IMPLANTED. A POST-EXPLANT EXAMINATION OF THE LEAD'S FIXED HELIX, SHOWED ENTWINED CARDIAC TISSUE. THE PHYSICIAN STRONGLY INDICATED A PREFERENCE FOR AN EXTENDABLE-RETRACTABLE HELIX MECHANISM. FINAL SENSING/IMPEDANCE/THRESHOLDS WERE SATISFACTORY WITH THE NEW LEAD. THE PATIENT WAS IN A STABLE CONDITION AT THE CONCLUSION OF THE PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
313475 FINELINE II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4471

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| L| R